SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clean Science And Technology Ltd (CLEAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543318 NSE: CLEAN Chemicals | Small Cap | Clean Science Share Price

₹794.30 6.15 (0.78%)

As on 05-Jun'26 16:59

Clean Science And Technology Ltd (CLEAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543318 NSE: CLEAN Chemicals | Small Cap | Clean Science Share Price

₹794.30 6.15 (0.78%)

As on 05-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹8,376 Cr.
Current Price
₹794.3
52-Week Low / High
₹653 / 1,565
TTM EPS
₹23.6
TTM Sales
₹815 Cr.
Book Value per Share
₹154.8
P/E Ratio
33.34
Lower than its 5-year historical median
Industry PE
50.2
Price to Book (P/B)
5.09
Lower than its 5-year historical median
Price to Sales (P/S)
10.27
Lower than its 5-year historical median
EV/EBITDA
21.99
Lower than its 5-year historical median
Dividend Yield
0.51%
Profitability Efficiency
Return on Equity (ROE)
21.91%
Outperforms industry median
Return on Capital Employed (ROCE)
29.28%
Outperforms industry median
Return on Assets (ROA)
18.58%
Operating Profit Margin
43.3%
Net Profit Margin
31.69%
Gross Profit Margin
47.2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
16.83%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
18.34%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
18.01%
Asset Quality
Promoter Holding
51.29%
Pledged shares (%) of Promoter's holding (%)
0.64%
Reserves
₹1,635 Cr.
Equity
₹10.6 Cr.
Face Value
₹1
All Time Low / High
₹652.80 / 2698.25

Clean Science And Technology stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Clean Science And Technology Ltd a good quality company?
Clean Science And Technology Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Clean Science And Technology Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Clean Science And Technology Ltd vs industry peers?
Clean Science And Technology Ltd revenue CAGR is 17.08%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Clean Science And Technology Ltd?
Promoters hold 51.29% of the Clean Science And Technology Ltd, with 0.64% of their stake pledged, indicating low pledge risk.
Q.1 Stock return of Clean Science And Technology Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -20.36% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Clean Science And Technology Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 37.5%59.2%58.9%60.5%46.6%45.4%29.7%29.3%-
Value Creation
Index
1.83.43.43.52.52.41.21.2-

Growth Parameters

Sales 241393419512685936789922815
Sales YoY Gr.-63.1%6.6%22.2%33.7%36.6%-15.6%16.8%-
Adj EPS 4.18.1131820.628.222.427.123.6
YoY Gr.-97.6%60%38.5%14.8%37%-20.7%20.9%-
BVPS (₹) 16.624.132.250.872.395.8114.2136.9154.8
Adj Net
Profit
46.491.7138191219300238288251
Cash Flow from Ops. 4584.7160193127299277279-
Debt/CF from Ops. 00000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA17.1%10.4%16.8%
Adj EPS NA15.9%9.6%20.9%
BVPSNA33.5%23.7%19.9%
Share Price - - -17.4% -46.9%

Key Financial Parameters

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
24.739.944.843.233.433.621.321.516.2
Op. Profit
Mgn %
30.734.844.350.643.943.142.843.343.1
Net Profit
Mgn %
19.223.332.837.231.932.130.131.230.8
Debt to
Equity
000000000
Working Cap
Days
092101103125114152154135
Cash Conv.
Cycle
043431623385756109

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales241393419512685936789922
Operating Expenses + 168257234253385533452523
Manufacturing Costs304955629112298112
Material Costs113171129124225326275326
Employee Cost 1625314435454650
Other Costs 912182434403235
Operating Profit 73137186259300403338399
Operating Profit Margin (%) 30.4%34.8%44.3%50.6%43.8%43.1%42.8%43.3%
Other Income + 511112630393836
Exceptional Items 00000000
Interest 10000111
Depreciation 811141725364444
Profit Before Tax 70137182267305405331391
Tax 21394369761028398
Profit After Tax 4998140198229304248292
PAT Margin (%) 20.2%24.9%33.3%38.7%33.4%32.4%31.4%31.7%
Adjusted EPS (₹)4.38.613.118.721.528.623.327.5
Dividend Payout Ratio (%)8.70%10.90%8.60%13.40%15.10%17.50%21.50%21.80%

Valuation of Clean Science - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1882723425407681,0181,2131,455
Share Capital 1111111111111
Reserves 1862713415297581,0071,2031,444
Debt +03300000
Long Term Debt00000000
Short Term Debt02200000
Minority Interest00000000
Trade Payables26223661102809274
Others Liabilities 223049595461141172
Total Liabilities 2363284306609251,1591,4461,701

Fixed Assets

Net Fixed Assets +101126166186296427401364
Gross Block136171225261395561579586
Accumulated Depreciation3545597599135178222
CWIP 1435544424
Investments 1876134233247428666907
Inventories2937355388109110105
Trade Receivables40607074154148162184
Cash Equivalents 2998162912915
Others Assets 16151544673196122
Total Assets 2363284306609251,1591,4461,701

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 4585160193127299277279
PBT 70137182267305405331391
Adjustment 657513241519
Changes in Working Capital -9-2113-14-121-367-34
Tax Paid -22-36-42-66-69-94-75-96
Cash Flow From Investing Activity + -18-95-107-186-124-245-228-221
Capex -32-39-51-84-130-125-13-9
Net Investments 14-58-56-10758-6101
Others 0105-52-59-214-213
Cash Flow From Financing Activity + -5-11-55-6-0-55-53-52
Net Proceeds from Shares 00000111
Net Proceeds from Borrowing 0-0000000
Interest Paid -0-0-0-0-0-0-1-0
Dividend Paid -4-11-13-30-56-53-53
Others -10-43-30-000
Net Cash Flow 22-21-314-0-36

Financial Ratio

PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)25.9542.5345.4344.9634.9433.9922.2121.91
ROCE (%)37.4559.1858.9460.4546.6345.4129.7329.28
Asset Turnover Ratio1.031.41.110.940.860.90.610.59
PAT to CFO Conversion(x)0.920.871.140.970.550.981.120.96
Working Capital Days
Receivable Days59.7046.1056.4051.3060.7058.8071.5068.30
Inventory Days43.7030.7031.2031.2037.6038.4050.7042.70
Payable Days8551.9081.90142.70132.50102.20113.9092.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.64
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Clean Science And Technology Ltd FAQs

The current trading price of Clean Science on 05-Jun-2026 16:59 is ₹794.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Clean Science stood at ₹8,376.3 Cr

The latest P/E ratio of Clean Science as of 04-Jun-2026 is 33.34.

The latest P/B ratio of Clean Science as of 04-Jun-2026 is 5.09.

The 52-week high of Clean Science is ₹1,565 and the 52-week low is ₹652.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Clean Science is ₹815 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Clean Science And Technology Ltd is a good quality company.

The key valuation ratios of Clean Science And Technology Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Clean Science And Technology Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Clean Science And Technology Ltd

Clean Science and Technology is among the few companies globally focused entirely on developing newer technologies using in-house catalytic processes, which are eco-friendly and cost competitive. This has enabled company to emerge as the largest manufacturer globally of certain specialty chemicals in terms of installed manufacturing capacities as of March 31, 2021. The company’s continued focus on product identification, process innovation, catalyst development, significant scale of operations as well as its measures towards strategic backward integration have all contributed to its success as one of the fastest growing and among the most profitable specialty chemical companies globally.

The company manufactures functionally critical specialty chemicals such as Performance Chemicals (i.e. MEHQ, BHA and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals (i.e. 4-MAP and Anisole). The company’s specialty chemicals have a wide range of applications that cater to a diverse base of customers across industries. Its customers include manufacturers and distributors in India as well as other regulated international markets including China, Europe, the United States of America, Taiwan, Korea, and Japan. In Fiscal 2021, revenue from operations for sales outside India represented 67.86% of its total revenue from operations, respectively. It has two certified production facilities in India strategically located at Kurkumbh (Maharashtra), in close proximity to the JNPT port from where it exports majority of its products.

Business area of the company

The company is among the leading companies in India to have commercialized use of environment-friendly processes to manufacture certain specialty chemicals, at global capacities.

Awards, accreditations and recognitions

  • 2018: First award in L-I - Basic Chemicals, Pharmaceuticals and Cosmetic Products category for export performance in the year 2015-16 and felicitation with memento and certificate of honour by the Directorate of Industries, Government of Maharashtra.
  • 2019: Winner of SME Elite Jury Round conducted by the ICICI Bank.
  • 2019: Felicitated with memento and certificate of honour in LSI- Basic Chemicals, Pharmaceuticals and Cosmetic Products category for export performance in the year 2016-17 by the Directorate of Industries, Government of Maharashtra.
  • 2019: Felicitated with the Company of the Year - Chemical award by Zee Business Dare to Dream Awards, Season 2.

Major events and milestones

  • 2009: Commenced manufacturing MEHQ and Guaiacol.
  • 2010: Commenced original cycle start date for Quality Management System and Environmental Management System for ISO certification.
  • 2011: Commenced manufacturing 4 MAP.
  • 2014: Commenced manufacturing BHA.
  • 2016: Entered into a memorandum of understanding with the Government of Maharashtra whereby the Government of Maharashtra will facilitate in obtaining necessary permissions/ registrations/ approvals/ clearances/ fiscal incentives from the concerned departments to enable investment of Rs 807.40 million in Maharashtra in a time bound manner.
  • 2017: Commenced manufacturing Anisole.
  • 2019: Commenced manufacturing AP.
  • 2020: Commenced manufacturing DCC.
  • 2021: Allotment of land admeasuring 67,053 sq mts in the ADDL Kurkumbh (Patas) Industrial Area.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×